Overview Dividends

(CPB) Campbell’s - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1344291091

Soups, Sauces, Broths, Cookies, Crackers, Chips

Packaged Foods & Meats
Market Cap in USD: 9,122m

IPO / Inception: 1985-07-01
Return 12m vs S&P 500: -40.8%

EPS (Earnings per Share)

EPS CAGR: -46.78%
EPS Trend: -35.2%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 1.00%
Rev. Trend: 52.8%

Last SUE: -0.56
Qual. Beats: 0

Dividends

Dividend Yield	5.16%
Yield on Cost 5y	3.70%
Yield CAGR 5y	1.40%
Payout Consistency	70.8%
Payout Ratio	52.4%

Risk via 10d forecast
Volatility	24.4%
Value at Risk 5%th	39.2%
Relative Tail Risk	-2.38%

Reward TTM
Sharpe Ratio	-1.37
Alpha	-36.53
CAGR/Max DD	-0.34

Character TTM
Hurst Exponent	0.335
Beta	0.185
Beta Downside	0.153

Drawdowns 3y
Max DD	42.38%
Mean DD	21.53%
Median DD	21.47%

Description: CPB Campbell’s November 04, 2025

The Campbell’s Company (NYSE: CPB) manufactures and markets a broad portfolio of food and beverage brands across two segments-Meals & Beverages and Snacks-serving retail and food-service channels in the United States, Canada, and Latin America. The Meals & Beverages segment includes iconic items such as Campbell’s soups, Swanson broths, V8 juices, and Pacific Foods plant-based beverages, while the Snacks segment houses Pepperidge Farm cookies, Goldfish crackers, Kettle Brand chips, and Snyder’s pretzels, among others.

Key recent metrics: CPB reported FY 2023 net sales of roughly $5.7 billion, with the Snacks segment delivering a 4.5 % higher contribution margin than the Meals & Beverages segment, reflecting a strategic shift toward higher-margin, on-the-go products. Inflation-driven input-cost volatility and a consumer tilt toward healthier, plant-based options remain primary economic drivers for the business; CPB’s acquisition of Pacific Foods in 2020 positions it to capture growth in the “better-for-you” category, which the packaged-foods industry is seeing a 6-7 % CAGR in North America. Additionally, the company’s exposure to private-label competition in mass discounters adds execution risk to its pricing power.

If you want to explore CPB’s valuation sensitivities, cash-flow projections, and peer-group benchmarks in more depth, ValueRay’s analytics platform offers a convenient way to continue the research.

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (602.0m TTM) > 0 and > 6% of Revenue (6% = 615.2m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA 0.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -6.57% (prev -14.38%; Δ 7.81pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 1.14b > Net Income 602.0m (YES >=105%, WARN >=100%)

Net Debt (7.08b) to EBITDA (1.57b) ratio: 4.50 <= 3.0 (WARN <= 3.5)

Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (299.0m) change vs 12m ago 0.34% (target <= -2.0% for YES)

Gross Margin 30.30% (prev 30.83%; Δ -0.53pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 68.06% (prev 63.25%; Δ 4.81pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.30 (EBITDA TTM 1.57b / Interest Expense TTM 345.0m) >= 6 (WARN >= 3)

Altman Z'' 1.69

(A) -0.05 = (Total Current Assets 2.23b - Total Current Liabilities 2.91b) / Total Assets 14.90b

(B) 0.32 = Retained Earnings (Balance) 4.69b / Total Assets 14.90b

(D) 0.43 = Book Value of Equity 4.69b / Total Liabilities 10.99b

Total Rating: 1.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 58.27

1. Piotroski 2.50pt

2. FCF Yield 4.43%

3. FCF Margin 6.99%

4. Debt/Equity 1.85

5. Debt/Ebitda 4.50

6. ROIC - WACC (= 3.86)%

7. RoE 15.51%

8. Rev. Trend 52.79%

9. EPS Trend -35.22%

What is the price of CPB shares?

As of November 27, 2025, the stock is trading at USD 30.24 with a total of 7,002,831 shares traded.
Over the past week, the price has changed by -1.75%, over one month by -3.66%, over three months by -4.24% and over the past year by -32.20%.

Is CPB a buy, sell or hold?

Campbell’s has received a consensus analysts rating of 3.13. Therefor, it is recommend to hold CPB.

Strong Buy: 4
Buy: 2
Hold: 12
Sell: 3
Strong Sell: 2

What are the forecasts/targets for the CPB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	34.4	13.7%
Analysts Target Price	34.4	13.7%
ValueRay Target Price	29.4	-2.8%

CPB Fundamental Data Overview November 26, 2025

Market Cap USD = 9.12b (9.12b USD * 1.0 USD.USD)
P/E Trailing = 15.2289
P/E Forward = 12.87
P/S = 0.8896
P/B = 2.4155
P/EG = 0.7848
Beta = -0.055
Revenue TTM = 10.25b USD
EBIT TTM = 1.14b USD
EBITDA TTM = 1.57b USD
Long Term Debt = 6.06b USD (from longTermDebt, last quarter)
Short Term Debt = 858.0m USD (from shortTermDebt, last quarter)
Debt = 7.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.08b USD (from netDebt column, last quarter)
Enterprise Value = 16.20b USD (9.12b + Debt 7.21b - CCE 132.0m)
Interest Coverage Ratio = 3.30 (Ebit TTM 1.14b / Interest Expense TTM 345.0m)
FCF Yield = 4.43% (FCF TTM 717.0m / Enterprise Value 16.20b)
FCF Margin = 6.99% (FCF TTM 717.0m / Revenue TTM 10.25b)
Net Margin = 5.87% (Net Income TTM 602.0m / Revenue TTM 10.25b)
Gross Margin = 30.30% ((Revenue TTM 10.25b - Cost of Revenue TTM 7.15b) / Revenue TTM)
Gross Margin QoQ = 30.16% (prev 29.17%)
Tobins Q-Ratio = 1.09 (Enterprise Value 16.20b / Total Assets 14.90b)
Interest Expense / Debt = 1.18% (Interest Expense 85.0m / Debt 7.21b)
Taxrate = 21.20% (39.0m / 184.0m)
NOPAT = 896.8m (EBIT 1.14b * (1 - 21.20%))
Current Ratio = 0.77 (Total Current Assets 2.23b / Total Current Liabilities 2.91b)
Debt / Equity = 1.85 (Debt 7.21b / totalStockholderEquity, last quarter 3.90b)
Debt / EBITDA = 4.50 (Net Debt 7.08b / EBITDA 1.57b)
Debt / FCF = 9.87 (Net Debt 7.08b / FCF TTM 717.0m)
Total Stockholder Equity = 3.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.04% (Net Income 602.0m / Total Assets 14.90b)
RoE = 15.51% (Net Income TTM 602.0m / Total Stockholder Equity 3.88b)
RoCE = 11.45% (EBIT 1.14b / Capital Employed (Equity 3.88b + L.T.Debt 6.06b))
RoIC = 8.01% (NOPAT 896.8m / Invested Capital 11.20b)
WACC = 4.15% (E(9.12b)/V(16.33b) * Re(6.69%) + D(7.21b)/V(16.33b) * Rd(1.18%) * (1-Tc(0.21)))
Discount Rate = 6.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 77.66% ; FCFE base≈697.4m ; Y1≈668.9m ; Y5≈652.8m
Fair Price DCF = 39.11 (DCF Value 11.64b / Shares Outstanding 297.7m; 5y FCF grow -5.44% → 3.0% )
EPS Correlation: -35.22 | EPS CAGR: -46.78% | SUE: -4.0 | # QB: 0
Revenue Correlation: 52.79 | Revenue CAGR: 1.00% | SUE: -0.56 | # QB: 0

Additional Sources for CPB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle